Previous 10 | Next 10 |
2023-10-26 05:23:00 ET Summary The Ithaka Group is an independent investment boutique that specializes in managing high-quality, concentrated growth equity portfolios. The market’s retracement coincided with fading expectations for a “Fed pivot,” with Wall Str...
2023-10-25 08:45:23 ET Palm Beach, FL – October 25, 2023 – FinancialNewsMedia.com News Commentary – Recently, as the assorted global diabetes markets, such as drugs, devices and therapy continue to see an increased revenue yearly, so has the Diabetes Care Ma...
2023-10-23 15:26:24 ET More on Insulet Insulet: Losing More Weight Insulet: High Growth Not Translating To Economic Value For Shareholders (Rating Downgrade) Insulet Corporation (PODD) Q2 2023 Earnings Call Transcript Diabetes device stocks gain after Abbott ...
2023-10-23 00:58:41 ET Summary Narratives are powerful drivers of stock prices and can fluctuate prices in either direction. GLP-1 injectables like Wegovy and Mounjaro have a disruptive narrative that affects the valuation of various sectors. AI is currently facing reassessmen...
2023-10-21 12:14:00 ET More on Boston Scientific, DexCom, etc. Intuitive Surgical, Inc. (ISRG) Q3 2023 Earnings Call Transcript Intuitive Surgical: When Paying A Premium Makes Sense Stryker: Don't Buy This Dividend Champion (Yet) Roth MKM starts Stryker with ...
2023-10-19 01:20:00 ET Summary Baron Health Care Fund invests in companies engaged in the research, development, production, sale, delivery, or distribution of products and services related to the health care industry. The Fund trailed the Benchmark by 217 basis points this quarte...
2023-10-18 14:54:09 ET More on Abbott Laboratories, DexCom, etc. Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript Abbott Laboratories Triumphs Over Challenges: A Tale Of Resilience Abbott Laboratories: Buy This Fairly Valued Dividend King For Consistently R...
2023-10-18 09:53:00 ET Diabetes care and aesthetics. Those are two areas of healthcare that should provide investors with ample growth opportunities in the long run. Two companies that are in solid positions to capitalize on that potential are DexCom (NASDAQ: DXCM) and InMode ...
2023-10-16 15:15:04 ET Shares of DexCom (NASDAQ: DXCM) surged higher on Monday, gaining as much as 5.3%. As of 3:04 p.m. ET, the stock was still up 3.6%. The catalyst that sent the medical device maker higher was bullish commentary by one Wall Street analyst. Leerink ana...
2023-10-16 14:48:23 ET The market is in very good shape, said Hennessy Funds’ chief market strategist Neil Hennessy. In a CNBC interview on Monday, he pointed out that all three indexes are up. ( DJI ) up 13.07%, compared to last year. ( SP500 ) up 19.13%, compa...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...